bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.07.28.741291

MetaAMI: A Novel Meta-Learning Approach for Predicting In-Hospital Mortality in Acute Myocardial Infarction

Abstract

Acute myocardial infarction (AMI) is one of the leading cardiovascular diseases worldwide and remains a major cause of mortality. Early risk prediction can help clinicians identify high risk patients shortly after admission and support timely monitoring and individualized treatment. Previous AMI risk assessment approaches predominantly rely on a single model structure or fixed feature representation, which may limit their ability to capture diverse risk related patterns and reduce predictive performance. To address these challenges, we propose MetaAMI, a random projection based meta-learning framework for AMI outcome prediction. Specifically, patients were selected based on ICD-9 and ICD-10 diagnostic codes for AMI from the Medical Information Mart for Intensive Care IV (MIMIC-IV) v3.1 database. Features were transformed through multiple random projections, with each random projection generating a distinct lower dimensional feature representation. Subsequently, baseline classifiers were trained on each lower dimension representation to predict in-hospital mortality among AMI patients. The predictions were aggregated to construct an integrated feature representation, which was used as input to a meta-learner architecture. By effectively integrating complementary information from diverse baseline models, the meta-learner refined the decision boundary and enhanced overall predictive performance. Survival analysis and SHapley Additive exPlanations (SHAP) analysis were further performed to evaluate clinical utility and interpret the model predictions. Benchmarking results based on MIMIC-IV dataset suggested that our MetaAMI consistently outperformed all the baseline classifiers across seven evaluation metrics including Accuracy, Area Under the Curve (AUC), F1 Score, G-Measure, Jaccard Index, Youden J, and Matthews Correlation Coefficient (MCC). In addition, feature importance analysis showed clinically relevant predictors of in-hospital mortality. In summary, MetaAMI provides an effective and robust solution for machine learning based AMI risk prediction. We anticipate that the application of MetaAMI will have a positive impact on clinical risk stratification and personalized treatment strategies for AMI.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Tuerhanbayi, B., Fan, X., Wang, J., Wan, S.. 2026-08-01. MetaAMI: A Novel Meta-Learning Approach for Predicting In-Hospital Mortality in Acute Myocardial Infarction. https://doi.org/10.64898/2026.07.28.741291

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Senescence-associated KRAS upregulation in peripheral T cells links to premature coronary artery disease

Aims: Premature coronary artery disease (PCAD) lacks specific molecular drivers, and the role of immunosenescence is unclear. We investigated whether aging-related gene dysregulation in T cells contributes to PCAD. Methods: We combined bulk transcriptomics of PBMCs from 12 PCAD patients and 21 controls, single-cell RNA sequencing of PBMCs and human atherosclerotic plaques, weighted gene co-expression network analysis, gene perturbation network analysis, and molecular docking. Results: KRAS was identified as a hub gene intersecting PCAD-associated genes and aging-related genes. Single-cell analysis showed KRAS upregulation predominantly in effector CD8+ T cells, which exhibited the highest senescence scores that were further elevated in disease. Network perturbation of KRAS strongly impacted the cell killing pathway. KRAS-high effector CD8+ T cells were detected in coronary and carotid plaques, displaying enhanced cytotoxicity, exhaustion, and senescence features. Additionally, a candidate small molecule was computationally predicted to bind inactive KRAS. Conclusions: Elevated KRAS expression in senescent, cytotoxic CD8+ T cells is associated with PCAD, bridging immunosenescence and premature atherosclerosis. This finding provides a novel biomarker candidate and potential therapeutic entry point, awaiting further functional validation.

bioinformatics↗

Targeted finetuning enables co-folding models to learn ligand-induced protein conformational states

Advances in protein structure prediction have enabled all-atom protein-ligand co-folding models that predict bound conformations directly from sequence and small-molecule structure. However, these models often fail to generalize to novel binding sites or alternative protein conformational states, limiting their utility for chemical biology and drug discovery. Here we show this limitation reflects training data bias rather than architectural constraints and can be overcome through targeted finetuning. Using ten previously unseen X-ray structures of Werner (WRN) helicase from a drug discovery program, we finetune Boltz-1 to learn both an allosteric binding site and a large conformational change locking the enzyme in an inactive state, while preserving accuracy on the ATP-bound state. The finetuned model generalizes to different chemical series and transfers the conformational logic across RecQ-family helicases in a binding-site sequence-dependent manner. This approach provides a blueprint for adapting foundation models as new structural and mechanistic data emerge, enabling co-folding networks to capture ligand-induced conformational switches and binding poses absent from their training data but central to biological regulation and therapeutic intervention.

bioinformatics↗

Benchmarking single-cell foundation models for aging biology

Single cell foundation models (scFMs) provide representations of cellular states, but their utility across biological questions in aging research remains unclear. We established a benchmark of cellular representations for aging research, evaluating ten general-purpose scFMs, three aging-specific models and conventional methods across five biological questions using more than 2.5 million single cell transcriptomes. Using frozen pretrained representations, Geneformer performed best among scFMs for chronological age prediction and age pseudotime concordance, although 2,000 highly variable genes achieved higher mean performance. Several scFMs captured positive molecular age shifts across three disease contexts, consistent with reported aging-associated changes. SCimilarity performed well for rare cellular state identification across out-of-distribution datasets, exceeding aging specific models and conventional baselines. At the gene level, scGPT showed the highest recovery of reference TF target interactions, including aging-related regulatory hubs. Overall, scFMs supported diverse aging analyses, but performance depended on the biological question, highlighting their utility for rare cellular state identification and regulatory analysis.

bioinformatics↗